Abacus Global Management Inc（ABX）資訊與事件ABXAbacus Global Management Inc

Abacus Global Management Files Motion to Amend Defamation Complaint

Abacus Global Management has filed a Motion for Leave to File a Second Amended Complaint in its ongoing defamation lawsuit against defendants Coventry First and Alan Buerger, who co-founded Coventry and serves as its Executive Chairman. The company said, "The proposed filing details Coventry and Buerger's rampant use of false and misleading statements and includes a claim for defamation per se which carries punitive damages. Coventry's potential liability for the conduct described in the complaint may exceed 100 million dollars...The proposed amended complaint catalogs nearly 20 distinct false and misleading statements about Abacus, its business model, and its use of third-party life expectancy data, repeated during public appearances and in direct appeals to media sources by Coventry and Buerger. The complaint alleges four counts: defamation, defamation by implication, violation of Florida's Deceptive and Unfair Trade Practices Act, and defamation per se; the Court already denied Coventry and Buerger's motion to dismiss the first three claims on June 25, 2026. The complaint adds Coventry and Buerger's recent selective and misleading use of discovery materials in an August 4, 2026 press release. If granted, the proposed amended complaint will show that Coventry's and Buerger's recent public attacks are their latest publication of previously discredited statements-filed weeks after a federal court denied Coventry's motion to dismiss and allowed the case to proceed to depositions. Abacus's proposed second amended complaint details the dozens of false and misleading statements made by Coventry and Mr. Buerger."

Abacus Global Authorizes $100 Million Share Repurchase Program

Abacus Global announced that its Board of Directors has authorized a $100 million share repurchase program, commencing August 17, 2026. This authorization aligns with the Company's capital allocation framework and builds on the approximately $80 million of the Company's common stock repurchased under prior authorized programs since December 2023.

Sees Q2 Revenue at $73.02M, Consensus $66.09M

Sees Q2 revenue $73.02M, consensus $66.09M.